Orchestra BioMed
OBIO
OBIO
43 hedge funds and large institutions have $70.3M invested in Orchestra BioMed in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
42% less capital invested
Capital invested by funds: $121M → $70.3M (-$51.1M)
Holders
43
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$600K | |
| 2 | +$290K | |
| 3 | +$195K | |
| 4 |
GWMR
GC Wealth Management RIA
Cambridge,
Massachusetts
|
+$117K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$75.6K |
Top Sellers
| 1 | -$272K | |
| 2 | -$216K | |
| 3 | -$173K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$163K |
| 5 |
BlackRock
New York
|
-$145K |